Literature DB >> 12193157

Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.

Mary A Cotter1, Alison M Jack, Norman E Cameron.   

Abstract

Elevated protein kinase C activity has been linked to the vascular and neural complications of diabetes. The aim of the present study was to examine the involvement of the beta-isoform of protein kinase C in abnormalities of neuronal function, neural tissue perfusion and endothelium-dependent vasodilation in diabetes, by treatment with the selective inhibitor LY333531 (10 mg.kg(-1).day(-1)). Diabetes was induced in rats by streptozotocin; the duration of diabetes was 8 weeks. Nerve conduction velocity was monitored, and responses to noxious mechanical and thermal stimuli were estimated by the Randall-Sellito and Hargreaves tests respectively. Sciatic nerve and superior cervical ganglion blood flow were measured by microelectrode polarography and hydrogen clearance. Vascular responses were examined using the in vitro mesenteric bed preparation. An 8-week period of diabetes caused deficits in sciatic motor (20%) and saphenous nerve sensory (16%) conduction velocity, which were reversed by LY333531. Diabetic rats had mechanical and thermal hyperalgesia. LY333531 treatment did not affect mechanical thresholds, but corrected thermal hyperalgesia. Sciatic nerve and superior cervical ganglion blood flow were both reduced by 50% by diabetes; this was almost completely corrected by 2 weeks of LY333531 treatment. Diabetes caused a 32% reduction in vasodilation of the mesenteric vascular bed in response to acetylcholine, mediated by nitric oxide and endothelium-derived hyperpolarizing factor. When the former was abolished during nitric oxide synthase inhibition, an 80% diabetic deficit in the remaining relaxation was noted. LY333531 treatment attenuated the development of these defects by 64% and 53% respectively. Thus protein kinase C beta contributes to the neural and vascular complications of experimental diabetes; LY333531 is a candidate for further study in clinical trials of diabetic neuropathy and vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193157     DOI: 10.1042/cs1030311

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  22 in total

1.  Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.

Authors:  Aditya Goel; Yingmin Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Cardiovasc Res       Date:  2007-07-04       Impact factor: 10.787

2.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

Review 3.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

4.  Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Authors:  Olga Ilnytska; Valeriy V Lyzogubov; Martin J Stevens; Viktor R Drel; Nazar Mashtalir; Pal Pacher; Mark A Yorek; Irina G Obrosova
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

5.  Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetes.

Authors:  Joshua A Beckman; Allison B Goldfine; Alison Goldin; Adnan Prsic; Sora Kim; Mark A Creager
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

6.  Sural nerve pathology in diabetic patients with minimal but progressive neuropathy.

Authors:  R A Malik; S Tesfaye; P G Newrick; D Walker; S M Rajbhandari; I Siddique; A K Sharma; A J M Boulton; R H M King; P K Thomas; J D Ward
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

7.  Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress.

Authors:  Mohammadali Mirshekar; Mehrdad Roghani; Mohsen Khalili; Tourandokht Baluchnejadmojarad; Saiedeh Arab Moazzen
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

Review 8.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

10.  The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats.

Authors:  Norman E Cameron; Mary A Cotter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-13       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.